Healthcare -
Biotechnology - NASDAQ - US
$ 29.55
1.41 %
$ 4.6 B
Market Cap
-295.5
P/E
Price Target
Average
39.88%
Revenue Forecast
Estimate
76.03%
EBIT
Estimate
--266.08%
Net Income
Estimate
259.21%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
TG Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for TGTX of $41.3 , with forecasts ranging from
a
low of
$20 to a high of $55 .
TGTX Lowest Price Target
Wall Street Target
20 USD
-32.32%
TGTX Average Price Target
Wall Street Target
41.3 USD
39.88%
TGTX Highest Price Target
Wall Street Target
55 USD
86.13%
REVENUE FORECAST
Revenue Forecast Chart TGTX
EBIT FORECAST
EBIT Forecast Chart TGTX
NET INCOME FORECAST
Net Income Chart TGTX